Susan M Hochschwender

Title: The Innovative Contributions of Susan M Hochschwender

Introduction

Susan M Hochschwender is a notable inventor based in Del Mar, California. She has made significant contributions to the field of biochemistry, particularly in the immobilization of biologically active molecules. Her work has implications for various applications, including affinity chromatography and assay systems.

Latest Patents

Susan M Hochschwender holds a patent for the immobilization of biologically active molecules by changing the oxidation state of a chelating agent. In her patented method, a chelating agent is covalently bonded to a biologically active molecule, such as an enzyme or antibody. The biologically active molecule is then contacted with a support containing a bound transition metal ion. This process allows the metal ion to be chelated by the chelating agent, and the oxidation state of the metal ion is altered through treatment with an oxidizing or reducing agent. The transition metal ions used in her invention include Co(II), Cr(II), or Ru(III), which can be changed to Co(III), Cr(III), or Ru(II), respectively. The chelating agents she utilizes can include iminodiacetic acid, nitrilotriacetic acid, and various other complexing agents. This innovative approach enables the immobilization of multiple biologically active molecules at a metal ion site on the support.

Career Highlights

Throughout her career, Susan has worked with prominent companies such as Eli Lilly and Company and Hybritech Incorporated. Her experience in these organizations has contributed to her expertise in the field of biochemistry and patent development.

Collaborations

Susan has collaborated with notable colleagues, including Leslie D Anderson and James A Cook. These partnerships have likely enriched her research and innovation efforts.

Conclusion

Susan M Hochschwender's contributions to the field of biochemistry through her innovative patent demonstrate her significant role as an inventor. Her work continues to influence the development of new technologies in the immobilization of biologically active molecules.